Ken Griffin Sol Gel Technologies Ltd. Call Options Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
Call Options
3 transactions
Others Institutions Holding SLGL
# of Institutions
23Shares Held
7.7MCall Options Held
200Put Options Held
300-
Phoenix Holdings Ltd. Givatayim, L32.57MShares$2.16 Million0.04% of portfolio
-
Armistice Capital, LLC New York, NY2.08MShares$1.75 Million0.03% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$1.03 Million0.02% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$773,0790.02% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY482KShares$404,6690.06% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $19.4M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...